Central Serous Chorioretinopathy

Showing 1 - 25 of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta

Completed
  • Central Serous Chorioretinopathy
  • Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
  • Cairo, Egypt
    Kasr alainy faculty of medicine
May 5, 2023

Central Serous Chorioretinopathy Trial (100µm laser spot diameter micropulse laser, 200µm laser spot diameter micropulse laser)

Not yet recruiting
  • Central Serous Chorioretinopathy
  • 100μm laser spot diameter micropulse laser
  • 200μm laser spot diameter micropulse laser
  • (no location specified)
Jan 13, 2023

Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using

Not yet recruiting
  • Age-Related Macular Degeneration
  • +5 more
  • OCT Imaging Using Device N
  • OCT Imaging Using Device C
  • New York, New York
    NYU Langone Health
Jan 6, 2023

Central Serous Chorioretinopathy Trial in Bordeaux (micropulse laser)

Not yet recruiting
  • Central Serous Chorioretinopathy
  • micropulse laser
  • Bordeaux, France
    CHU Bordeaux
Jan 9, 2023

Choroidal Blood Flow in Acute and Chronic Central Serous

Recruiting
  • Central Serous Chorioretinopathy
  • Stavanger, Norway
    Stavanger University Hospital, Department of Ophthalmology
Oct 18, 2022

Central Serous Chorioretinopathy Trial in East Melbourne, Glen Iris (2RT subthreshold nanosecond laser - active, 2RT

Recruiting
  • Central Serous Chorioretinopathy
  • 2RT subthreshold nanosecond laser - active
  • 2RT subthreshold nanosecond laser - sham
  • East Melbourne, Victoria, Australia
  • +1 more
Oct 17, 2022

Central Serous Chorioretinopathy, Therapy, Photodynamic Trial in Beijing (50% dose of photodynamic therapy, 70% dose of

Recruiting
  • Central Serous Chorioretinopathy
  • Therapy, Photodynamic
  • 50% dose of photodynamic therapy
  • 70% dose of photodynamic therapy
  • Beijing, Beijing, China
    Peking University People's Hospital
May 21, 2022

Central Serous Chorioretinopathy Trial in Hong Kong

Recruiting
  • Central Serous Chorioretinopathy
    • Hong Kong, Hong Kong
    • +2 more
    Apr 19, 2022

    Central Serous Chorioretinopathy, Irvine-Gass Syndrome, Pars Planitis Trial in Banha (Triamcinolone Acetonide)

    Recruiting
    • Central Serous Chorioretinopathy
    • +3 more
    • Triamcinolone Acetonide
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Apr 13, 2022

    Multiple Eye Fundus Diseases From Color Fundus Photograph

    Completed
    • Diabetic Retinopathy
    • +12 more
    • Software assisted imaging diagnosis
    • BeiJing, Beijing, China
    • +4 more
    Dec 28, 2021

    Eplerenone Versus PDT: Comparative Study by OCTA

    Completed
    • Central Serous Chorioretinopathy
    • Eplerenone
    • The patients underwent half fluence photodynamic therapy for 6 months
    • (no location specified)
    Oct 21, 2021

    OCT in Rare Chorioretinal Diseases

    Recruiting
    • Retinal Artery Occlusions
    • +4 more
      • Portland, Oregon
        Casey Eye Institute, Oregon Health & Science University
      Jul 13, 2021

      Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy Trial in

      Recruiting
      • Central Serous Chorioretinopathy
      • +2 more
      • Toronto, Ontario, Canada
        Sunnybrook Research Institute
      Jan 25, 2021

      Pilot Study on Deep Learning in the Eye

      Not yet recruiting
      • Central Serous Chorioretinopathy
      • +2 more
      • Image classification using deep learning algorithm
      • (no location specified)
      Jan 5, 2021

      Central Serous Chorioretinopathy, Chronic Central Serous Chorioretinopathy Trial in Ankara (Source of growth factors: autologous

      Completed
      • Central Serous Chorioretinopathy
      • Chronic Central Serous Chorioretinopathy
      • Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis
      • Ankara, Türkiye, Turkey
        Ankara University Biotechnology Institute
      Jan 9, 2020

      Macular Edema, Central Serous Chorioretinopathy, Retinal Vein Occlusion Trial in Bern (Selective retinal pigment epithelium

      Suspended
      • Macular Edema
      • +4 more
      • Selective retinal pigment epithelium laser therapy using the R:GEN Laser System
      • Bern, Switzerland
        Department of Ophthalmology, Bern University Hospital
      Oct 9, 2019

      Central Serous Chorioretinopathy Trial in Besançon (RTX1 IMAGIN EYE retinal camera)

      Terminated
      • Central Serous Chorioretinopathy
      • RTX1 IMAGIN EYE retinal camera
      • Besançon, France
        CHU Besançon
      Sep 13, 2019

      Optical Coherence Tomography Angiography and Central Serous

      Completed
      • Central Serous Chorioretinopathy
      • Optical Coherence Tomography Angiography (OCT-A)
      • (no location specified)
      May 10, 2019

      Central Serous Chorioretinopathy Trial (Selective retina therapy)

      Completed
      • Central Serous Chorioretinopathy
      • Selective retina therapy
      • (no location specified)
      Dec 29, 2018

      Central Serous Chorioretinopathy Trial in Seongnam-si, Seoul (R:GEN Selective Retina Therapy)

      Completed
      • Central Serous Chorioretinopathy
      • R:GEN Selective Retina Therapy
      • Seongnam-si, Korea, Republic of
      • +5 more
      Nov 28, 2018

      Central Serous Chorioretinopathy Trial in United States (25mg Eplerenone, Placebo)

      Completed
      • Central Serous Chorioretinopathy
      • 25mg Eplerenone
      • Placebo
      • Cherry Hill, New Jersey
      • +9 more
      Oct 8, 2018

      Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes

      Unknown status
      • Central Serous Chorioretinopathy
      • Half-dose photodynamic therapy
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 28, 2018

      Central Serous Chorioretinopathy Trial in Buenos Aires, Tel Aviv (Brinzolamide Ophthalmic)

      Unknown status
      • Central Serous Chorioretinopathy
      • Brinzolamide Ophthalmic
      • Buenos Aires, Argentina
      • +1 more
      May 29, 2018

      Central Serous Chorioretinopathy Trial in Boston (Eplerenone 50mg)

      Completed
      • Central Serous Chorioretinopathy
      • Eplerenone 50mg
      • Boston, Massachusetts
        New England Eye Center / Tufts Medical Center
      Apr 17, 2018

      Central Serous Chorioretinopathy, Tomography, Optical Coherence Trial in Beijing (OCTA-guided Photodynamic therapy, ICGA-guided

      Completed
      • Central Serous Chorioretinopathy
      • Tomography, Optical Coherence
      • OCTA-guided Photodynamic therapy
      • ICGA-guided Photodynamic therapy
      • Beijing, Beijing, China
        People's Hospital of Peking University
      Apr 14, 2018